Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

Clinical trial NCT00903461 · TERMINATED

Trial details

NCT number: NCT00903461
Sponsor: University of Pittsburgh
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma, Head And Neck

Start date: 2012-04-01
Primary completion: 2015-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.